What is VESTECK?
VESTECK, Inc., headquartered in West Chester, Pennsylvania, is a specialized medical device manufacturer focused on the production of advanced catheters designed for aortic repair. The company operates within the critical healthcare technology space, developing solutions that address complex cardiovascular needs. Its focus on manufacturing high-precision devices for aortic repair indicates a commitment to improving patient outcomes in a demanding medical field.
How much funding has VESTECK raised?
VESTECK has raised a total of $10.6M across 3 funding rounds:
Series A
$4.3M
Series A
$6M
Private Equity
$354K
Series A (2021): $4.3M with participation from DeepWork Capital, Ben Franklin Technology Partners Companies, Ocean Azul Partners, Delaware Crossing Investor Group, Robin Hood Ventures, and New World Angels
Series A (2022): $6M led by Robin Hood Ventures, New World Angels, Angel Star Ventures, DeepWork Capital, Ben Franklin Technology Partners Companies, Ocean Azul Partners, and BioAdvance
Private Equity (2025): $354K, investors not publicly disclosed
Key Investors in VESTECK
DeepWork Capital
DeepWork Capital is a venture capital firm that invests in growth-oriented early-stage companies within the technology and life science sectors, often taking a lead investor role and providing hands-on support.
Ocean Azul Partners
Ocean Azul Partners is an early-stage venture capital firm focused on supporting entrepreneurs with innovative technology solutions, leveraging the experience of its operators to add significant value to portfolio companies.
Delaware Crossing Investor Group
Delaware Crossing Investor Group is a network of executives and entrepreneurs providing capital and counsel to early-stage and growth-oriented companies, with a focus on the Mid-Atlantic region.
What's next for VESTECK?
The recent major strategic investment signifies a pivotal moment for VESTECK, likely enabling the company to scale its manufacturing capabilities, expand its research and development efforts, and potentially broaden its market reach. This influx of capital is expected to accelerate the commercialization of its aortic repair catheter technology, further solidifying its position in the competitive medical device industry and driving innovation in cardiovascular treatments.
See full VESTECK company page
